Breaking News

Adents, Microsoft Partner on Track & Trace Cloud Platform

October 26, 2016

Level 4 traceability solution is designed to centrally manage regulatory requirements

Adents, a software developer for unique product identification (UPID) and track & trace solutions, and Microsoft have partnered to jointly develop and commercialize the new Cloud platform Adents Prodigi. This Level 4 traceability solution is designed to centrally manage regulatory requirements imposed on the pharmaceutical industry, as well as allow laboratories and CMOs to leverage the data generated during the serialization and Track & Trace process.

Adents Prodigi provides unit identification and traceability, OEE and productivity monitoring across production sites, as well as real-time data visualization and analysis.

The demand for unique product identification solutions is driven by a global increase in regulations for the pharmaceutical industry. More than 80% of global drug production will need to be compliant with regulations regarding unit identification by 2019. This new process offers opportunities in terms of visibility on the life of products, but also represents a major challenge in terms of data management.

Adents Prodigi utilizes Microsoft Azure technologies and allows drug manufacturers to securely generate, exchange and control the large amount of data created through unit identification. The Adents Prodigi platform also integrates data analysis (including Microsoft Power BI) and machine learning tools, providing analytics capabilities for these new sources of information.

Adents Prodigi was developed collaboratively by a team of Adents and Microsoft experts, and can host business applications offered by third parties to exploit data stored on the platform.

“Our alliance with the leader of Business Intelligence will be a game changer on the global market for unit identification. Indeed, this will finally give the pharmaceutical industry the means to tap into the full potential of the wealth of information generated through serialization,” said Christophe Devins, founder and chief executive officer of Adents.

Related Packaging:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks